ScoreWhy is Zhejiang Tianyu Pharmaceutical Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 2.37% and Operating profit at -25.75% over the last 5 years
2
Flat results in Mar 26
- NET PROFIT(HY) At CNY -39.59 MM has Grown at -169.37%
3
With ROE of 2.58%, it has a very expensive valuation with a 1.08 Price to Book Value
- Over the past year, while the stock has generated a return of -13.21%, its profits have risen by 2.2% ; the PEG ratio of the company is 19.5
- At the current price, the company has a high dividend yield of 0.4
4
Below par performance in long term as well as near term
- Along with generating -13.21% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Zhejiang Tianyu Pharmaceutical Co., Ltd. for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Zhejiang Tianyu Pharmaceutical Co., Ltd.
-16.58%
0.45
39.40%
China Shanghai Composite
3.23%
1.20
14.07%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
2.37%
EBIT Growth (5y)
-25.75%
EBIT to Interest (avg)
2.47
Debt to EBITDA (avg)
4.25
Net Debt to Equity (avg)
0.48
Sales to Capital Employed (avg)
0.48
Tax Ratio
12.20%
Dividend Payout Ratio
12.32%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1.82%
ROE (avg)
4.61%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
74
Industry P/E
Price to Book Value
1.91
EV to EBIT
55.45
EV to EBITDA
20.12
EV to Capital Employed
1.64
EV to Sales
2.75
PEG Ratio
34.47
Dividend Yield
0.25%
ROCE (Latest)
2.97%
ROE (Latest)
2.58%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend17What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 909.18 MM
INVENTORY TURNOVER RATIO(HY)
Highest at 1.48 times
PRE-TAX PROFIT(Q)
At CNY 72.67 MM has Grown at 166.44%
NET PROFIT(Q)
At CNY 61.1 MM has Grown at 157.06%
DEBT-EQUITY RATIO
(HY)
Lowest at 42.36 %
NET SALES(Q)
Highest at CNY 1,199.06 MM
OPERATING PROFIT(Q)
Highest at CNY 191.68 MM
-11What is not working for the Company
NET PROFIT(HY)
At CNY 103.44 MM has Grown at -30.62%
RAW MATERIAL COST(Y)
Grown by 20.5% (YoY
DEBTORS TURNOVER RATIO(HY)
Lowest at 3.99 times
INTEREST(Q)
Highest at CNY 11.57 MM
Here's what is working for Zhejiang Tianyu Pharmaceutical Co., Ltd.
Net Sales
At CNY 1,199.06 MM has Grown at 54.05%
over average net sales of the previous four periods of CNY 778.37 MMMOJO Watch
Near term sales trend is very positive
Net Sales (CNY MM)
Pre-Tax Profit
At CNY 72.67 MM has Grown at 166.44%
over average net sales of the previous four periods of CNY 27.28 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (CNY MM)
Net Profit
At CNY 61.1 MM has Grown at 157.06%
over average net sales of the previous four periods of CNY 23.77 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (CNY MM)
Inventory Turnover Ratio
Highest at 1.48 times and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Operating Cash Flow
Highest at CNY 909.18 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Net Sales
Highest at CNY 1,199.06 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Operating Profit
Highest at CNY 191.68 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (CNY MM)
Debt-Equity Ratio
Lowest at 42.36 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Here's what is not working for Zhejiang Tianyu Pharmaceutical Co., Ltd.
Interest
At CNY 11.57 MM has Grown at 22.1%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Interest
Highest at CNY 11.57 MM
in the last five periods and Increased by 22.1% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Debtors Turnover Ratio
Lowest at 3.99 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Raw Material Cost
Grown by 20.5% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
Footer loading
